Technical Analysis for FAB - Fusion Antibodies PLC
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.75 | 0.00% | 0.00 |
FAB closed unchanged on Friday, April 19, 2024, on 11 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -1.32% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 11 hours ago |
| Down 1% | about 11 hours ago |
| Possible NR7 | about 11 hours ago |
| Up 1% | about 15 hours ago |
| Fell Below Previous Day's Low | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Fusion Antibodies PLC, formerly Fusion Antibodies, Ltd., is a United Kingdom-based cancer therapeutics developer. The Company develops and commercializes antibody-based therapeutics for cancer. The Company develops a range of antibody engineering services based around monoclonal antibodies. It focuses in the expression and purification of recombinant proteins and chimeric antibodies for the research, diagnostic and therapeutic markets. Its technology generates target specific antibodies from protein antigens. The Company's therapeutic and diagnostic research and development are offered as a service to pharmaceutical, biopharmaceutical and academic researchers.
Sector: Healthcare
Industry: Biotechnology
Keywords: Engineering Biotechnology Pharmaceutical Life Sciences Cancer Branches Of Biology Medical Specialties Biopharmaceutical As A Service Monoclonal Antibodies Antibodies Antibody Immunology Immune System Cancer Therapeutics Glycoproteins Monoclonal Recombinant Proteins
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Engineering Biotechnology Pharmaceutical Life Sciences Cancer Branches Of Biology Medical Specialties Biopharmaceutical As A Service Monoclonal Antibodies Antibodies Antibody Immunology Immune System Cancer Therapeutics Glycoproteins Monoclonal Recombinant Proteins
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 50.0 |
| 52 Week Low | 3.02 |
| Average Volume | 1,207,949 |
| 200-Day Moving Average | 5.15 |
| 50-Day Moving Average | 3.97 |
| 20-Day Moving Average | 3.88 |
| 10-Day Moving Average | 3.90 |
| Average True Range | 0.27 |
| RSI (14) | 43.50 |
| ADX | 20.58 |
| +DI | 15.48 |
| -DI | 12.47 |
| Chandelier Exit (Long, 3 ATRs) | 3.58 |
| Chandelier Exit (Short, 3 ATRs) | 4.32 |
| Upper Bollinger Bands | 4.10 |
| Lower Bollinger Band | 3.65 |
| Percent B (%b) | 0.22 |
| BandWidth | 11.37 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0075 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.87 | ||||
| Resistance 3 (R3) | 3.87 | 3.84 | 3.85 | ||
| Resistance 2 (R2) | 3.84 | 3.81 | 3.84 | 3.84 | |
| Resistance 1 (R1) | 3.79 | 3.79 | 3.78 | 3.79 | 3.84 |
| Pivot Point | 3.76 | 3.76 | 3.75 | 3.76 | 3.76 |
| Support 1 (S1) | 3.71 | 3.73 | 3.70 | 3.71 | 3.66 |
| Support 2 (S2) | 3.68 | 3.71 | 3.68 | 3.66 | |
| Support 3 (S3) | 3.63 | 3.68 | 3.65 | ||
| Support 4 (S4) | 3.63 |
